CNS-Sparing Histamine H3 Receptor Antagonist as a Candidate to Prevent the Diabetes-Associated Gastrointestinal Symptoms. (2022)
Attributed to:
Realising Unmet Potential in Translational Medical Science at Durham
funded by
UKRI
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/biom12020184
PubMed Identifier: 35204685
Publication URI: http://europepmc.org/abstract/MED/35204685
Type: Journal Article/Review
Volume: 12
Parent Publication: Biomolecules
Issue: 2
ISSN: 2218-273X